Tessera Therapeutics' new CEO, Michael Severino
Michael Severino trades in AbbVie perch for CEO role at Flagship’s gene medicines biotech Tessera
After a few years as vice chair and president at what is anticipated to become the world’s largest drugmaker and one of the industry’ …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
